1
|
Dordoe C, Huang W, Bwalya C, Wang X, Shen B, Wang H, Wang J, Ye S, Wang P, Xiaoyan B, Li X, Lin L. The role of microglial activation on ischemic stroke: Modulation by fibroblast growth factors. Cytokine Growth Factor Rev 2023; 74:122-133. [PMID: 37573252 DOI: 10.1016/j.cytogfr.2023.07.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2023] [Accepted: 07/29/2023] [Indexed: 08/14/2023]
Abstract
Stroke is one of the devastating clinical conditions that causes death and permanent disability. Its occurrence causes the reduction of oxygen and glucose supply, resulting in events such as inflammatory response, oxidative stress, and apoptosis in the brain. Microglia are brain-resident immune cells in the central nervous system (CNS) that exert diverse roles and respond to pathological process after an ischemic insult. The discovery of fibroblast growth factors (FGFs) in mammals, resulted to the findings that they can treat experimental models of stroke in animals effectively. FGFs function as homeostatic factors that control cells and hormones involved in metabolism, and they also regulate the secretion of proinflammatory (M1) and anti-inflammatory (M2) cytokines after stroke. In this review, we outline current evidence of microglia activation in experimental models of stroke focusing on its ability to exacerbate damage or repair tissue. Also, our review sheds light on the pharmacological actions of FGFs on multiple targets to regulate microglial modulation and highlighted their theoretical molecular mechanisms to provide possible therapeutic targets, as well as their limitations for the treatment of stroke. DATA AVAILABILITY: Not applicable.
Collapse
Affiliation(s)
- Confidence Dordoe
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China
| | - Wenting Huang
- The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China
| | - Canol Bwalya
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China
| | - Xue Wang
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China
| | - Bixin Shen
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China
| | - Hao Wang
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China
| | - Jing Wang
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China
| | - Shasha Ye
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China
| | - Peng Wang
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China
| | - Bao Xiaoyan
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China
| | - Xiaokun Li
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Research Units of Clinical Translation of Cell Growth Factors and Diseases Research, Chinese Academy of Medical Science, Wenzhou, Zhejiang 325035, China.
| | - Li Lin
- Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision, and Brain Health), School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China; Research Units of Clinical Translation of Cell Growth Factors and Diseases Research, Chinese Academy of Medical Science, Wenzhou, Zhejiang 325035, China.
| |
Collapse
|
2
|
Xincai S, Hui L, Zhonghai Z, Xiaoyan B, Lin C, Huating Y, Xingcai L. Microsatellite Polymorphism and Prokaryotic Expression of Mef2d in Xingyi Duck. Braz J Poult Sci 2021. [DOI: 10.1590/1806-9061-2020-1422] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- S Xincai
- Guizhou University College of Animal Science, China; Key Laboratory of Animal Genetics, Breeding and Reproduction in Guizhou Province, China
| | - L Hui
- Guizhou University College of Animal Science, China; Key Laboratory of Animal Genetics, Breeding and Reproduction in Guizhou Province, China
| | | | - B Xiaoyan
- Guizhou University College of Animal Science, China; Key Laboratory of Animal Genetics, Breeding and Reproduction in Guizhou Province, China
| | - C Lin
- Guizhou University College of Animal Science, China; Key Laboratory of Animal Genetics, Breeding and Reproduction in Guizhou Province, China
| | - Y Huating
- Guizhou University College of Animal Science, China; Key Laboratory of Animal Genetics, Breeding and Reproduction in Guizhou Province, China
| | - L Xingcai
- Guizhou University College of Animal Science, China; Key Laboratory of Animal Genetics, Breeding and Reproduction in Guizhou Province, China
| |
Collapse
|
4
|
Wenming D, Xiangke W, Xiaoyan B, Aixia W, Jingzhou D, Zuyi T. Comparative study on sorption/desorption of radioeuropium on alumina, bentonite and red earth: effects of pH, ionic strength, fulvic acid, and iron oxides in red earth. Appl Radiat Isot 2001; 54:603-10. [PMID: 11225696 DOI: 10.1016/s0969-8043(00)00311-0] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
The sorption and desorption of Eu(III) as a representative of trivalent lanthanides and actinides on bentonite, alumina, red earth and red earth treated to remove free iron oxides were comparatively investigated by using batch technique and radiotracer 152 + 154Eu. The effects of pH, ionic strength, fulvic acid, iron oxides in red earth and the sorption mechanism were also discussed. As compared to alumina and red earth, Eu(III) presents a considerable distribution coefficient (Kd) onto bentonite. It was found that the pH and the presence of clay minerals are the main factors dominating the sorption/desorption characteristic of Eu3+ in the soil, and that a sorption-desorption hysteresis on bentonite and red earth actually occurs. Furthermore, the main sorption mechanism of lanthanides onto bentonite, alumina and red earth is the formation of bridged hydroxo complexes with the surface, and there are negative effects of fulvic acid and free iron oxides in red earth on the sorption of Eu(III). The results of this paper indicate that the additivity rule on the sorption characteristic of a soil from the individual component's characteristics is not general.
Collapse
Affiliation(s)
- D Wenming
- Radiochemistry Laboratory, College of Chemistry and Chemical Engineering, Lanzhou University, People's Republic of China
| | | | | | | | | | | |
Collapse
|